These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24238891)

  • 1. Cardiac amyloidosis: diagnosis using delayed enhancement cardiac magnetic resonance imaging sequences.
    Mesquita D; Nobre C; Thomas B; Jalles Tavares N
    Rev Port Cardiol; 2013 Nov; 32(11):941-5. PubMed ID: 24238891
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac magnetic resonance imaging in cardiomyopathies that look alike.
    Yalcinkaya E; Celik M
    Rev Port Cardiol; 2014; 33(7-8):487. PubMed ID: 25150923
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to the letter to the editor "Cardiac magnetic resonance imaging in cardiomyopathies that look alike".
    Mesquita D; Nobre C; Thomas B; Jalles Tavares N
    Rev Port Cardiol; 2014; 33(7-8):489. PubMed ID: 25155000
    [No Abstract]   [Full Text] [Related]  

  • 4. Atrial enhancement by cardiovascular magnetic resonance in cardiac amyloidosis.
    Lyne JC; Petryka J; Pennell DJ
    Eur Heart J; 2008 Jan; 29(2):212. PubMed ID: 17704093
    [No Abstract]   [Full Text] [Related]  

  • 5. [MR imaging in cardiac amyloidosis--morphology, function and late enhancement].
    Hosch W; Libicher M; Ley S; Heye T; Schnabel P; Dengler TJ; Katus HA; Kauffmann GW; Kauczor HU; Kristen AV
    Rofo; 2008 Jul; 180(7):639-45. PubMed ID: 18561066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis.
    Lehrke S; Steen H; Kristen AV; Merten C; Lossnitzer D; Dengler TJ; Katus HA; Giannitsis E
    Amyloid; 2009 Dec; 16(4):187-95. PubMed ID: 19922329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CARDIAC AMYLOIDOSIS DIAGNOSED ON MRI.
    Lu P; Van Acker H; Waer P
    JBR-BTR; 2015; 98(1):48-9. PubMed ID: 26223068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed enhancement magnetic resonance imaging in nonischemic myocardial disease.
    Moraes GL; Higgins CB; Ordovas KG
    J Thorac Imaging; 2013 Mar; 28(2):84-92; quiz 93-5. PubMed ID: 23422782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of cardiac amyloidosis by magnetic resonance imaging due to a new mutation in the transthyretin gene.
    Damy T; Plante-Bordeneuve V; Valleix S
    Arch Cardiovasc Dis; 2012 Nov; 105(11):614-5. PubMed ID: 23177490
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular magnetic resonance in cardiac amyloidosis.
    Kwong RY; Falk RH
    Circulation; 2005 Jan; 111(2):122-4. PubMed ID: 15657385
    [No Abstract]   [Full Text] [Related]  

  • 11. [MR scanning of cardiac amyloidosis].
    Bjerre J; Gustafsson F; Andersen CB; Hove JD; Madsen PL
    Ugeskr Laeger; 2015 Aug; 177(32):V66463. PubMed ID: 26321583
    [No Abstract]   [Full Text] [Related]  

  • 12. Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings.
    Hosch W; Kristen AV; Libicher M; Dengler TJ; Aulmann S; Heye T; Schnabel PA; Schirmacher P; Katus HA; Kauczor HU; Longerich T
    Amyloid; 2008 Sep; 15(3):196-204. PubMed ID: 18925458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac amyloidosis presenting with paroxysmal atrial fibrillation.
    Kabach M; Zaiem F; Alraies MC
    QJM; 2015 Oct; 108(10):819-20. PubMed ID: 25524904
    [No Abstract]   [Full Text] [Related]  

  • 14. Ischaemic and non-ischaemic cardiomyopathies--cardiac MRI appearances with delayed enhancement.
    Jackson E; Bellenger N; Seddon M; Harden S; Peebles C
    Clin Radiol; 2007 May; 62(5):395-403. PubMed ID: 17398263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial pathology in cardiac amyloidosis: evidence from ECG and cardiovascular magnetic resonance.
    Leeson CP; Myerson SG; Walls GB; Neubauer S; Ormerod OJ
    Eur Heart J; 2006 Jul; 27(14):1670. PubMed ID: 16449244
    [No Abstract]   [Full Text] [Related]  

  • 16. MRI assessment of cardiac amyloidosis: experience of six cases with review of the current literature.
    Seeger A; Klumpp B; Kramer U; Stauder NI; Fenchel M; Claussen CD; Miller S
    Br J Radiol; 2009 Apr; 82(976):337-42. PubMed ID: 19029219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI in the assessment of non ischemic myocardial diseases.
    De Smet K; Verdries D; Tanaka K; De Mey J; De Maeseneer M
    Eur J Radiol; 2012 Jul; 81(7):1546-8. PubMed ID: 21392911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac amyloidosis: a practical approach to diagnosis and management.
    Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
    Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1 mapping in cardiac amyloidosis: can we get there from here?
    Ruberg FL
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):498-500. PubMed ID: 23498671
    [No Abstract]   [Full Text] [Related]  

  • 20. [Abnormal gadolinium kinetics in cardio MRI - always an indication of cardiac amyloidosis?].
    Baeßler B; Reuter H; Huntgeburth M; Bunck AC
    Rofo; 2015 Mar; 187(3):189-91. PubMed ID: 25184217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.